Related references
Note: Only part of the references are listed.Activities of Vancomycin, Ceftaroline, and Mupirocin against Staphylococcus aureus Isolates Collected in a 2011 National Surveillance Study in the United States
Sandra S. Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Oritavancin Activity against Staphylococcus aureus Causing Invasive Infections in U. S. and European Hospitals: a 5-Year International Surveillance Program
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals
Seth T. Housman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Clinical Laboratory-Based Assay Methodologies May Underestimate and Increase Variability of Vancomycin Protein Binding in Hospitalized Patients
Jared L. Crandon et al.
PHARMACOTHERAPY (2014)
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
Michael N. Neely et al.
THERAPEUTIC DRUG MONITORING (2012)
Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections Using In Vivo Microdialysis
Dora E. Wiskirchen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery
Christopher J. Payne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices
April Barbour et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery
K Skhirtladze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)